Biocryst Pharmaceuticals (BCRX) Payables: 2010-2015
Historic Payables for Biocryst Pharmaceuticals (BCRX) over the last 3 years, with Sep 2015 value amounting to $3.8 million.
- Biocryst Pharmaceuticals' Payables fell 88.28% to $3.8 million in Q3 2015 from the same period last year, while for Sep 2015 it was $45.8 million, marking a year-over-year decrease of 34.77%. This contributed to the annual value of $32.8 million for FY2014, which is 686.99% up from last year.
- Latest data reveals that Biocryst Pharmaceuticals reported Payables of $3.8 million as of Q3 2015, which was down 1.05% from $3.8 million recorded in Q2 2015.
- Over the past 5 years, Biocryst Pharmaceuticals' Payables peaked at $32.8 million during Q4 2014, and registered a low of $1.2 million during Q3 2013.
- For the 3-year period, Biocryst Pharmaceuticals' Payables averaged around $13.0 million, with its median value being $4.2 million (2013).
- Its Payables has fluctuated over the past 5 years, first soared by 2,500.00% in 2014, then tumbled by 88.28% in 2015.
- Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Payables stood at $2.5 million in 2011, then soared by 59.15% to $4.0 million in 2012, then increased by 5.03% to $4.2 million in 2013, then spiked by 686.99% to $32.8 million in 2014, then plummeted by 88.28% to $3.8 million in 2015.
- Its last three reported values are $3.8 million in Q3 2015, $3.8 million for Q2 2015, and $5.3 million during Q1 2015.